Argos Therapeutics' Arcelis(TM) Immunotherapy for Renal Cell Carcinoma ... - SYS-CON Media (press release) PDF Print
SYS-CON Media (press release)CHICAGO, Oct. 1 /PRNewswire/ -- Argos Therapeutics announced that its Arcelis immunotherapy for renal cell carcinoma (RCC), AGS-003, demonstrated favorable ...Argos Therapeutics' Arcelis™ Immunotherapy for Renal Cell Carcinoma

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.